[On the treatment of allergic and vasomotor rhinopathy with a new antihistaminic].
作者信息
Fuchs T
出版信息
Wien Med Wochenschr. 1969 Apr 5;119(14):264-6.
PMID:4388734
Abstract
摘要
相似文献
1
[On the treatment of allergic and vasomotor rhinopathy with a new antihistaminic].
Wien Med Wochenschr. 1969 Apr 5;119(14):264-6.
2
[Paroxysmal rhinitis. Diagnostic and therapeutic possibilities in allergic and vasomotor rhinopathies].
MMW Munch Med Wochenschr. 1974 Mar 1;116(9):427-32.
3
[Experiences with an antihistaminic as a dosage aerosol. Lyssipoll in allergic and non-allergic vasomotor rhinopathy].
Med Welt. 1966 Nov 5;45:2436-8.
4
[Clinical experience with HS-592 (a new antihistaminic) for so-called allergic rhinitis].
Penn Dent J (Phila). 1970 Mar;73(2):319-22.
5
[Clinical study of a new antihistaminic agent, Tavist].
Vie Med Can Fr. 1972 Feb;1(2):151-5.
6
Mold hyposensitization in rhinitis: a two-year study.
Ann Allergy. 1972 Mar;30(3):122-5.
7
[The therapy of pollinosis].
Z Allgemeinmed. 1973 Nov 10;49(31):1499-504.
8
[Clinical trial of a new antihistaminic for allergic rhinitis].
Lakartidningen. 1970 Jul 1;67(27):3105-8.
9
Open-label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitis.氮卓斯汀鼻喷雾剂治疗季节性变应性鼻炎和非变应性血管运动性鼻炎患者的开放标签评估
Curr Med Res Opin. 2005 Apr;21(4):611-8. doi: 10.1185/030079905X41408.
10
[A clinical comparison of two drug combinations in allergic rhinitis].
Lakartidningen. 1974 Feb 20;71(8):717-8.
Zotero 插件